Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Mechanism of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension

NCT06055452 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06055452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06055452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Mechanism of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Recruiting
Start date
January 19, 2024
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pre-heart failure